Location: Menlo Park, CA
CIK: 0001819257 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 12, 2026
Total Value: $646M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 276,000 | $51.69M | 8.0% | $187.28 | — | COM | 76155X100 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 37,120 | $20.11M | 3.1% | $541.83 | — | COM | 91307C102 |
| BNTX | BIONTECH SE | 134,429 | $12.51M | 1.9% | $93.05 | — | SPONSORED ADS | 09075V102 |
| CCCC | C4 THERAPEUTICS INC | 1,608,815 | $7.513M | 1.2% | $4.67 | — | COM STK | 12529R107 |
| IVA | INVENTIVA SA | 1,967,171 | $7.436M | 1.2% | $3.78 | — | ADS | 46124U107 |
| SNSE | FAETH THERAPEUTICS INC | 175,050 | $4.376M | 0.7% | $25.00 | — | COM NEW | 81728A207 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 206,500 (+70.3%) | $27.52M (+103.8%) | 4.3% | $104.87 | — | SPONSORED ADS | 00370M103 |
| PHVS | PHARVARIS N V | 671,209 (+36.1%) | $23.21M (+66.7%) | 3.6% | $24.62 | — | COM | N69605108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 260,500 (+13.3%) | $30.5M (+43.5%) | 4.7% | $68.55 | — | COM | 604749101 |
| RCUS | ARCUS BIOSCIENCES INC | 355,800 (+82.5%) | $10.97M (+160.4%) | 1.7% | $25.18 | — | COM | 03969F109 |
| ELVN | ENLIVEN THERAPEUTICS INC | 212,500 (+6.3%) | $10.78M (+37.6%) | 1.7% | $25.12 | — | COM | 29337E102 |
| DNTH | DIANTHUS THERAPEUTICS INC | 108,000 (+15.0%) | $10.53M (+33.6%) | 1.6% | $36.87 | — | COM | 252828108 |
| ALLO | ALLOGENE THERAPEUTICS INC | 5,050,000 (+46.4%) | $10.5M (+24.8%) | 1.6% | $1.86 | — | COM | 019770106 |
| ONC | BEONE MEDICINES LTD | 90,020 (+11.8%) | $25.65M (+7.3%) | 4.0% | $300.97 | — | SPONSORED ADS | 07725L102 |
| DBVT | DBV TECHNOLOGIES S A | 909,474 (+31.1%) | $14.92M (+3.0%) | 2.3% | $19.14 | — | SPONSORED ADS | 23306J309 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 157,500 | $25.75M | 4.0% | $73.51 | — | — | 457669307 |
| LEGN | LEGEND BIOTECH CORP | 990,000 | $17.91M | 2.8% | $18.09 | — | — | 52490G102 |
| NKTR | NEKTAR THERAPEUTICS | 210,000 | $15.11M | 2.3% | $48.33 | — | — | 640268306 |
| CELC | CELCUITY INC | 95,000 | $10.84M | 1.7% | $47.06 | — | — | 15102K100 |
| MRK | MERCK & CO INC | 80,000 | $9.623M | 1.5% | $114.28 | — | — | 58933Y105 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 1,625,000 | $6.776M | 1.0% | $3.32 | — | — | 46489V302 |
| DFTX | DEFINIUM THERAPEUTICS INC | 331,000 | $6.256M | 1.0% | $16.29 | — | — | 24477V105 |
| HROW | HARROW INC | 165,209 | $5.825M | 0.9% | $47.86 | — | — | 415858109 |
| TARA | PROTARA THERAPEUTICS INC | 1,030,846 | $5.371M | 0.8% | $6.18 | — | — | 74365U107 |
| CTMX | CYTOMX THERAPEUTICS INC. | 1,085,790 | $5.103M | 0.8% | $5.23 | — | — | 23284F105 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 136,315 | $3.783M | 0.6% | $22.39 | — | — | 045396207 |
| SYRE | SPYRE THERAPEUTICS INC | 1,000 | $50,440 | 0.0% | $26.13 | — | — | 00773J202 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | 8,020,928 (-1.8%) | $284M (+25.5%) | 44.0% | $7.21 | — | SHS | G76279101 |
| COGT | COGENT BIOSCIENCES INC | 425,000 (-28.7%) | $16.45M (-28.3%) | 2.5% | $32.44 | — | COM | 19240Q201 |
| ARGX | ARGENX SE | 23,000 (-37.4%) | $21.34M (-20.4%) | 3.3% | $686.33 | — | SPONSORED ADR | 04016X101 |
| KYMR | KYMERA THERAPEUTICS INC | 47,500 (-52.5%) | $5.447M (-34.6%) | 0.8% | $46.83 | — | COM | 501575104 |
| BLTE | BELITE BIO INC | 110,000 (-5.7%) | $16.94M (-9.0%) | 2.6% | $159.44 | — | SPONSORED ADS | 07782B104 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 370,000 (-7.6%) | $9.701M (+2.8%) | 1.5% | $26.20 | — | COM | 03969K108 |
| XENE | XENON PHARMACEUTICALS INC | 220,000 (-3.1%) | $13.28M (+0.6%) | 2.1% | $41.99 | — | COM | 98420N105 |
| EYPT | EYEPOINT INC | 720,000 (-9.4%) | $10.3M (+0.5%) | 1.6% | $8.84 | — | COM NEW | 30233G209 |